Clermont-Ferrand (France), June 22, 2026 (7:45 am CEST). CARBIOS, (Euronext Growth Paris: ALCRB), announces the results of its Annual Ordinary and Extraordinary General Meeting held on June 18, 2026.
Shareholders physically present, represented or voting by post accounted for 27.72% of the shares composing the Company’s share capital and carrying voting rights, and 27.73% of total voting rights.
All resolutions on the agenda were approved with more than 87% of votes in favour.
This meeting provided an opportunity to present the Group’s recent progress and its priorities for 2026. In this context, the creation of the joint venture between Carbios and Wankai, named Kaibio Biotechnology Co. Ltd (“Kaibio”), was announced. Kaibio will be responsible for the construction and operation of the first PET biorecycling plant in China under a licensing agreement. In this regard, Carbios emphasized that Kaibio will only be granted the right to use Carbios’ technology, while Carbios retains full ownership of its patents.
“I would like to thank all shareholders for their participation and support. This General Meeting was an opportunity to highlight the maturity of our technology in the field of enzymatic recycling of plastics and textiles. This technological leadership enables us to roll out our licensing model, starting with Wankai in China and expanding soon to other geographical areas, to drive long-term value for Carbios and its shareholders.”
All documentation relating to this General Meeting is available on the Company’s website (www.carbios.com) and detailed voting results will be published in due course.
As of June 19, 2026, the Board of Directors comprises eight directors, including four independent members*: Ms Isabelle Parize, BOLD (Business Opportunities for L’Oréal Development), Michelin Ventures, Mr Vincent Kamel, Ms Jennifer Saenz*, Ms Karine Auclair*, Mr Mateus Schreiner Garcez Lopes* and Ms Julie Sonies*, as well as one non-voting director: Copernicus Wealth Management.
